Quarterly report pursuant to Section 13 or 15(d)

Note 1 - History and Basis of Presentation: Income/loss Per Common Share: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Tables)

v3.3.0.814
Note 1 - History and Basis of Presentation: Income/loss Per Common Share: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2015
Tables/Schedules  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following instruments are currently antidilutive and have been excluded from the calculations of diluted income or loss per share at September 30, 2015 and 2014, as follows:

                

 

September 30,

 

2015

2014

 

 

 

Convertible notes and accrued interest

24,700,000

23,500,000

Convertible preferred stock - Series B

11,818,181

11,818,181

Warrants

3,083,332

3,083,332

Compensation-based stock options and warrants

92,470,222

72,645,311

 

132,071,735

111,046,824